Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Astrana Health (ASTH)
NASDAQ:ASTH
Earnings Data
Report Date
Feb 27, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.1Last Year’s EPS
0.26Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: -39.61%
|Next Earnings Date:Feb 27, 2025
Earnings Call Sentiment|Neutral
Astrana Health demonstrated strong revenue growth and expanded its membership and full risk revenue. However, there were declines in net income and quarterly EBITDA, and challenges with Medicaid cost trends. The acquisition of Collaborative Health Systems presents both opportunities and short-term challenges.Company Guidance
During Astrana Health's third-quarter 2024 earnings call, the company provided comprehensive guidance for the year ending December 31, 2024. Revenue for the quarter reached $478.7 million, with adjusted EBITDA at $45.2 million. On a year-to-date basis, adjusted EBITDA grew by 15% from $117.6 million in the first three quarters of 2023 to $135.3 million in the first three quarters of 2024. The company expects full-year revenue to range between $1.95 billion and $2.03 billion, and adjusted EBITDA to be between $165 million and $175 million. Earnings per diluted share for the year are projected to be between $1.06 and $1.19. Following the acquisition of Collaborative Health Systems, Astrana Health anticipates a negative $4 million adjusted EBITDA impact in Q4 but expects approximately $450 million in revenue contribution in full year 2025, with breakeven adjusted EBITDA contribution by the end of 2025. The company remains focused on increasing its full risk business, which now makes up approximately 61% of total capitation revenue, with a goal of reaching around two-thirds by January 1, 2025.Significant Revenue Growth
Astrana Health reported total revenue of $478.7 million, a 37% increase from the prior year period.
Adjusted EBITDA Growth
Year-to-date adjusted EBITDA grew 15% from $117.6 million in the first 3 quarters of 2023 to $135.3 million in the first 3 quarters of 2024.
Successful Membership Expansion
Membership reached around 1 million members as of September 30, with over 200 primary care providers and over 900 specialists added to the network.
Increased Full Risk Revenue
Approximately 61% of total capitation revenue now comes from the full risk business, up from 46% the previous year.
Collaborative Health Systems Acquisition
The acquisition of Collaborative Health Systems, adding around 2,500 primary care providers, closed as of October 4, 2024.
---
ASTH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ASTH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $59.08 | $46.96 | -20.51% |
| Aug 07, 2024 | $46.36 | $46.85 | +1.06% |
| May 07, 2024 | $37.93 | $38.09 | +0.42% |
| Feb 27, 2024 | $43.54 | $43.77 | +0.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Astrana Health (ASTH) report earnings?
Astrana Health (ASTH) is schdueled to report earning on Feb 27, 2025, TBA Not Confirmed.
What is Astrana Health (ASTH) earnings time?
Astrana Health (ASTH) earnings time is at Feb 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ASTH EPS forecast?
ASTH EPS forecast for the fiscal quarter 2024 (Q4) is 0.1.
---